EligibleTrials

Clinical trials recruiting for Stage IVA Hepatocellular Carcinoma AJCC v8

3
Recruiting trials
3
US states with sites
1
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 1Not applicable 1

Drugs and treatments being studied

InterventionTrials
Atezolizumab1
Cabozantinib S-malate1
Cyclophosphamide1
Nab-paclitaxel1
Neoantigen Peptide Vaccine1
Pembrolizumab1
Radiation Therapy (RT)1
Sargramostim1

Where trials are recruiting (top US states)

StateRecruiting trials
California1
Florida1
Texas1

Top cities

Houston, Texas 1Jacksonville, Florida 1San Francisco, California 1Walnut Creek, California 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Stage IVA Hepatocellular Carcinoma AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.

Stage IVB Hepatocellular Carcinoma AJCC v8 3Stage IV Hepatocellular Carcinoma AJCC v8 5Metastatic Hepatocellular Carcinoma 6Stage IVB Uterine Corpus Cancer AJCC v8 4Stage IVA Uterine Corpus Cancer AJCC v8 4Stage IV Renal Cell Cancer AJCC v8 9Stage IIIC2 Uterine Corpus Cancer AJCC v8 3Stage IIIC1 Uterine Corpus Cancer AJCC v8 3Stage IIIC Uterine Corpus Cancer AJCC v8 3Stage IIIB Uterine Corpus Cancer AJCC v8 3

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Stage IVA Hepatocellular Carcinoma AJCC v8 trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.